Vistin Pharma — Director's Dealing 2015

May 27, 2015

Mandatory notification of trade in Vistin Pharma ASA

Mandatory notification of trade in Vistin Pharma ASA

On May 26 2015,Ferncliff Listed DAI AS, a company

controlled by board member Øystein Stray Spetalen,

acquired 1 870 subscription rights an average

purchase price of NOK 10.50,- per subscription right

After the transaction Øystein Stray Spetalen and

associated companies hold 2 171 205 subscription

rights in Vistin Pharma ASA corresponding to 12.7 %

of the outstanding shares if the subscription rights

are executed (based on 17 054 935 outstanding

shares).